English | Spanish
ecancer
Login Register

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part this project.
Register for free Already have an account? Login
Videos [486]
News [997]
Articles [135]
Editorials [8]
Conferences [45]
elearning [8]
Key messages from IGCS 2010
Dr Richard Barakat - Memorial Sloan-Kettering Cancer Center, New York, USA
Key messages from IGCS 2010 ( Dr Richard Barakat - Memorial Sloan-Kettering Cancer Center, New York, USA )
7 Dec 2010
GOG-218: Bevacizumab plus standard chemo for ovarian cancer
Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA
GOG-218: Bevacizumab plus standard chemo for ovarian cancer ( Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA )
10 Nov 2010
Bevacizumab as part of standard first line treatment of ovarian cancer
Prof Jonathan Ledermann - University College London, UK
Bevacizumab as part of standard first line treatment of ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
10 Nov 2010
The ICON7 trial
Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK
The ICON7 trial ( Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK )
1 Nov 2010
ESTRO 2010 - Snapshots from the conference
European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-1...
ESTRO 2010 - Snapshots from the conference ( European Society for Therapeutic Radiology and Oncology meeting, Barcelona, 12-16th September 2010 )
25 Oct 2010
ESTRO 2010 Highlights
Professor Gordon McVie - European Institute of Oncology
ESTRO 2010 Highlights ( Professor Gordon McVie - European Institute of Oncology )
6 Oct 2010
The role of ESTRO in the development of gynaecological cancer treatment
Prof Richard Pötter - Medical University of Vienna, Austria
The role of ESTRO in the development of gynaecological cancer treatment ( Prof Richard Pötter - Medical University of Vienna, Austria )
6 Oct 2010
The rise in rates of endometrial cancer
Dr Paul Cornes, Bristol Oncology Centre, UK
The rise in rates of endometrial cancer ( Dr Paul Cornes, Bristol Oncology Centre, UK )
3 Aug 2010
Optimising adjuvant therapy in the treatment of early stage endometrial cancer p...
Dr Carien Creutzberg - Leiden University Medical Center, Netherlands
Optimising adjuvant therapy in the treatment of early stage endometrial cancer patients ( Dr Carien Creutzberg - Leiden University Medical Center, Netherlands )
2 Aug 2010
Key advances in ovarian cancer from ASCO 2010
Dr Prof Jonathan Ledermann - UCL Cancer Institute, UK
Key advances in ovarian cancer from ASCO 2010 ( Dr Prof Jonathan Ledermann - UCL Cancer Institute, UK )
22 Jul 2010
Ovarian cancer research
Professor Stan Kaye - Institute of Cancer Research, London, UK
Ovarian cancer research ( Professor Stan Kaye - Institute of Cancer Research, London, UK )
20 Jul 2010
NKTR-102: a new drug for treating platinum-resistant or refractory ovarian cance...
Professor Ignace Vergote - Catholic University of Leuven, Belgium
NKTR-102: a new drug for treating platinum-resistant or refractory ovarian cancer ( Professor Ignace Vergote - Catholic University of Leuven, Belgium )
25 Jun 2010
<1...363738394041>
Donate to ecancer

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
The content on this site is intended for healthcare professionals only
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2021 ecancer, all rights reserved
UK registered charity number: 1176307